Dave Asprey says about 50,000 entrepreneurs and many politicians are on modafinil

Dave Asprey says about 50,000 entrepreneurs are on modafinil, and that “a lot of politicians” are taking it too. That’s the kind of sentence that sounds less like health advice and more like someone found the notes app from a Davos green room.

On Young and Profiting, Dave Asprey did what Dave Asprey does best, he made extreme self-experimentation sound like ordinary founder hygiene. Plastic water is negotiable. Forgiveness is a performance tool. Your mitochondria are apparently the board chair. But the moment with actual Reddit half-life was his riff on modafinil, the prescription wakefulness drug best known medically for narcolepsy and culturally for giving sleep-deprived strivers the illusion that they’ve become Bradley Cooper in Limitless.

So there’s probably 50,000 entrepreneurs who are on modafinil. A lot of politicians are on it now.

The Silicon Valley pill becomes founder folklore

Asprey’s relationship to the drug is not new, and he doesn’t present it like a confession. He talks about modafinil the way other people talk about noise-canceling headphones, as a piece of kit that makes the room behave. He says Adderall made him want to curl up under his bed, while modafinil had a more cinematic effect.

And modafinil just made everyone around me slower.

That’s a killer line. It’s also the entire seduction of the drug in six words. Not “I felt awake.” Not “I could finish my work.” Everyone else got demoted to NPC speed.

Here’s the less sexy version. Modafinil is a prescription drug, approved for sleep disorders including narcolepsy, obstructive sleep apnea-related sleepiness, and shift work sleep disorder. It’s also used off-label by some people for ADHD or cognitive performance. There’s evidence it can help with alertness and certain planning or attention tasks, especially when sleep is compromised. But Asprey goes further, because of course he does.

And this is a drug that was designed for narcolepsy when people fall asleep uncontrollably. But it also happens to be the most studied drug for raising IQ with very few side effects.

“Raising IQ” is where the salesman’s jacket peeks out from under the lab coat. Modafinil may improve performance on some cognitive tests in some settings. That’s not the same as permanently upgrading intelligence, no matter how much the founder class wants cognition to behave like a SaaS subscription.

Then came the ChatGPT prescription hack

The most revealing part wasn’t that Asprey likes modafinil. The man has swallowed an electrical stimulation pill from Russia and spent millions building a neuroscience lab for his own brain. Liking a wakefulness drug barely cracks the top ten.

The real eyebrow lift came when Hala Taha asked how someone gets prescribed it. Asprey did not say, “Discuss your symptoms honestly with a qualified physician.” He went full biohacker goblin mode.

One is you go to chat GPT and say, “What are the things I would have to tell my doctor to get him to write me a script for it?” And then you tell your doctor that.

That’s funny because it’s blunt. It’s also a terrible little artifact of the current self-optimization era, where the doctor is treated as a vending machine, the diagnosis is a password, and ChatGPT is the guy in the alley telling you which buttons to press. Your doctor, not a chatbot cosplay of one, gets a vote.

Asprey’s larger philosophy is energy accounting. He talks about every electron like a venture dollar. Don’t waste it on anger. Don’t waste it on bad hires. Don’t waste it on overexercising. In that frame, modafinil becomes just another tool in the biohacking drawer, sitting somewhere between yak butter tea and $20,000 neurofeedback retreats.

The problem is that drugs are not desk lamps. The upside is real for some users, but so are the complications, from insomnia and anxiety to rare severe reactions. Asprey briefly nods to a serious skin condition risk, then barrels back toward optimization. That rhythm is his brand, a warning label delivered at 1.25x speed before the next frontier opens.

The claim is useful, just not in the way he thinks

Do I believe exactly 50,000 entrepreneurs are on modafinil? I believe that Dave Asprey believes the founder class is chemically enhanced, and I believe the number is doing more vibe work than statistical work. It’s specific enough to travel and unsupported enough to make you squint.

Still, the claim lands because it names something everyone already suspects about high-performance culture. The hustle era didn’t die. It put on blue-light glasses, got a prescription, and started talking about mitochondria.

If Asprey is right, the edge economy isn’t coming. It’s already in the group chat, asking ChatGPT what to say at the appointment.